Old Mission Capital’s Evolent Health EVH Stock Holding History

Old Mission Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,179	Closed	-$337K	–	1418
2021 Q4	$337K	Buy	+12,179	New	+$349K	0.01%	717

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Old Mission Capital's EVH Position: Q1 2022 in Review

Old Mission Capital sold out of Evolent Health (EVH) in Q1 2022, closing a stake of 12,179 shares — an estimated $337K sold.

Old Mission Capital first reported a position in EVH in Q4 2021 and held it in 1 quarter. The position peaked at $337K in Q4 2021. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

Old Mission Capital reported no remaining Evolent Health position as of Q1 2022 after selling out during the quarter.
Old Mission Capital sold 12,179 Evolent Health shares in Q1 2022, an estimated $337K.
Old Mission Capital first reported a position in Evolent Health in Q4 2021 and held it in 1 quarter.
Old Mission Capital's Evolent Health position peaked at $337K in Q4 2021.
218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Old Mission Capital's 13F filing for Q1 2022, filed 13 May 2022.